SRSF2 and acute myeloid leukemia: In CSF3R-mutated patients other than AML, we also observed 2 out of 7 patients (28.6%) harboring CSF3R and two concomitant mutations of SF3B1 and SRSF2 (Table 1; Fig. 3).